ondansetron and amifostine anhydrous

ondansetron has been researched along with amifostine anhydrous in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Gallegos-Castorena, S; Guerrero-Avendaño, G; Martínez-Avalos, A; Medina-Sansón, A; Mohar-Betancourt, A; Zapata-Tarrés, M	1

Reviews

1 review(s) available for ondansetron and amifostine anhydrous

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for ondansetron and amifostine anhydrous

Article	Year
Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin. Pediatric hematology and oncology, 2007, Volume: 24, Issue:6 Topics: Adolescent; Amifostine; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Calcium Gluconate; Child; Cisplatin; Doxorubicin; Female; Hearing Loss; Heart Diseases; Humans; Hypocalcemia; Infusions, Intra-Arterial; Infusions, Intravenous; Kidney Diseases; Male; Neoadjuvant Therapy; Ondansetron; Osteosarcoma; Prospective Studies; Severity of Illness Index; Treatment Outcome; Vomiting	2007

Article

Year

Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin.

Pediatric hematology and oncology, 2007, Volume: 24, Issue:6

Topics: Adolescent; Amifostine; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Calcium Gluconate; Child; Cisplatin; Doxorubicin; Female; Hearing Loss; Heart Diseases; Humans; Hypocalcemia; Infusions, Intra-Arterial; Infusions, Intravenous; Kidney Diseases; Male; Neoadjuvant Therapy; Ondansetron; Osteosarcoma; Prospective Studies; Severity of Illness Index; Treatment Outcome; Vomiting

2007

Other Studies

1 other study(ies) available for ondansetron and amifostine anhydrous

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004